Rapid Medical Ltd.

www.rapid-medical.com ; www.rapid-medical-us.com

High-Tech Company

TECH VERTICALS

Biotechnology, Catheters, Healthtech, Life Sciences, Medical Devices, MedTech, Minimally Invasive

General Data

Sector	Medical Devices
Company Stage:	Revenue Growth
Established	2008
Number of Employees	150
Employees in Israel	90
Reg. Number:	abCDe

DESCRIPTION

Rapid is a developer of interventional endovascular devices, designed to focus on ischemic and hemorrhagic stroke. The company utilizes proprietary manufacturing techniques, which consist of a controllable, fully visible retriever that treats ischemic stroke patients and also consists of a controllable aneurysm neck-bridging device that helps physicians to respond in real-time to the anatomy and tailor the approach to every patient for better procedural outcomes, enabling patients to receive treatment for peripheral arterial disease.

TECHNOLOGY

Rapid developed a device for removing blood clots from medium-sized blood vessels in the brain.

Products and Phases

Product	Phase
Comaneci	FDA Approved CE Approved
The Comaneci is a fully-visible aneurysm remodeling device. It acts as a temporary bridge used to aid in the coiling processes while minimizing the risk of coil protrusion or prolapse. Once the coiling procedure is completed the device is removed from the parent artery.
Columbus	FDA Approved CE Approved
A steerable Guidewire
Pele	CE Approved
Distal Access Catheter. Medical Device to treat patients with accute carotid occlusion.
Tigertriever	FDA Approved CE Approved
A revascularization device that was developed for medium-sized blood vessels. It is a tiny device that moves inside the artery, changing its shape to match the precise structure of the blood vessel, trapping the clot and restoring blood flow, while reducing pressure on the artery wall to prevent damage to the delicate tissue.

	TARGET MARKETS
	Vascular clinics, hospitals, physicians.

	BUSINESS MODEL
	B2B

COMPETITORS

Medtronic Inc. , Johnson & Johnson Inc. , Stryker Corp.

SERVICE PROVIDERS

Company Name	Type
abC Defghij	Law Firm

CONTACT INFO

Expand / Collapse All

Main Address: Yoqneam Ilit, Israel

Address	HaCarmel St. Carmel Building
POB	337
City	Yoqneam Ilit
Country	Israel
Zip	2069200

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Frankfurt, Germany

Address	21 Westendstrasse
City	Frankfurt
Country	Germany
Zip	60325

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: London, United Kingdom

Address	167-169 Great Portland St., 2nd Floor
City	London
Country	United Kingdom
Zip	W1W 5PF

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Sunrise, United States

Address	1355 Shotgun Rd.
City	Sunrise
State/Province	FL
Country	United States
Zip	33326

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Wilmington, United States

Address	108 W. 13th St., Suite 100
City	Wilmington
State/Province	DE
Country	United States
Zip	19801

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. Ronen Eckhouse	CEO & Co-Founder
Ms. Michal Eran-Shriki	CFO	WakingApp (CFO)
Dr. Walid Haddad	Chief Clinical Officer	CardioGard (COO)
Mr. Giora Kornblau	CTO	TerraLab Ventures (CEO)
Mr. Eitan Havis	President
Mr. Yair Simes	VP, International Sales
Ms. Nadia Fainshtein	VP, Manufacturing & Operations	Pyramidion (Production Manager)
Mr. Joey Egidio	VP, Sales, USA
Dr. Shimon Eckhouse	Co-Founder	Agate (Advisory Board Member)
Mr. Danel Mayer	Co-Founder

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Chairman	Co-Founder, Rapid
abC Defghij	Board Member	Executive Director, CPE
abC Defghij	Board Member	CEO & Co-Founder, Rapid
abC Defghij	Board Member	CEO, CardioDex
abC Defghij	Board Member	Head of the Uro-Gynecology Clinic, Department of Obstetrics & Gynecology at the LIS Maternity Hospital, Tel Aviv Sourasky Medical Center
abC Defghij	Board Member	Partner, BRM Group
abC Defghij	Board Member	N\A
abC Defghij	Board Member	President, MicroPort NeuroTech Americas
abC Defghij	Board Member	Operating Partner, ARCHIMED
abC Defghij	Board Member	N\A
abC Defghij	Board Member	Managing Partner, JAM Capital Partners
abC Defghij	Observer	Managing Partner & Co-Founder, Deep Insight

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Fifth Round

Sep. 01, 2024

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Traditional Industry	abCDe

Fourth Round

May. 25, 2021

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Traditional Industry	abCDe	Led the round
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe

Third Round

Apr. 23, 2019

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe	Round co-leader
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Traditional Industry	abCDe	Round co-leader
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe

Second Round

Jul. 16, 2017

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe	Round co-leader
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe	Round co-leader
abC Defghij	Investment Company	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe

First Round

Aug. 01, 2016

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe

Seed

Sep. 01, 2008

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Jun. 01, 2020

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Jun. 01, 2019

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Jun. 01, 2018

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Government Agency	abCDe

Last Updated:	abCDe
IVC Number:	abCDe